Active 0 6 0 6 O
collagen 7 15 7 15 B-chronic_disease
vascular 16 24 16 24 I-chronic_disease
disease 25 32 25 32 I-chronic_disease
, 32 33 32 33 O
specifically 34 46 34 46 O
dermatomyositis 47 62 47 62 B-chronic_disease
with 63 67 63 67 O
a 68 69 68 69 O
creatinine 70 80 70 80 B-clinical_variable
phosphokinase 81 94 81 94 I-clinical_variable
( 95 96 95 96 I-clinical_variable
CPK 96 99 96 99 I-clinical_variable
) 99 100 99 100 I-clinical_variable
level 101 106 101 106 I-clinical_variable
above 107 112 107 112 O
normal 113 119 113 119 O
or 120 122 120 122 O
with 123 127 123 127 O
an 128 130 128 130 O
active 131 137 131 137 O
skin 138 142 138 142 B-chronic_disease
rash 143 147 143 147 I-chronic_disease
, 147 148 147 148 O
systemic 149 157 149 157 B-chronic_disease
lupus 158 163 158 163 I-chronic_disease
erythematosus 164 177 164 177 I-chronic_disease
, 177 178 177 178 O
or 179 181 179 181 O
scleroderma 182 193 182 193 B-chronic_disease

Any 0 3 194 197 O
continued 4 13 198 207 O
use 14 17 208 211 O
of 18 20 212 214 O
sex 21 24 215 218 B-treatment
hormonal 25 33 219 227 I-treatment
therapy 34 41 228 235 I-treatment
, 41 42 235 236 O
e.g. 43 47 237 241 O
, 47 48 241 242 O
birth 49 54 243 248 O
control 55 62 249 256 O
pills 63 68 257 262 O
, 68 69 262 263 O
ovarian 70 77 264 271 B-treatment
hormone 78 85 272 279 I-treatment
replacement 86 97 280 291 I-treatment
therapy 98 105 292 299 I-treatment

Any 0 3 300 303 O
prior 4 9 304 309 O
history 10 17 310 317 O
, 17 18 317 318 O
not 19 22 319 322 O
including 23 32 323 332 O
the 33 36 333 336 O
index 37 42 337 342 O
cancer 43 49 343 349 B-cancer
, 49 50 349 350 O
of 51 53 351 353 O
ipsilateral 54 65 354 365 O
invasive 66 74 366 374 B-cancer
breast 75 81 375 381 I-cancer
cancer 82 88 382 388 I-cancer
or 89 91 389 391 O
ipsilateral 92 103 392 403 O
DCIS 104 108 404 408 B-cancer
treated 109 116 409 416 O
with 117 121 417 421 O
radiation 122 131 422 431 B-treatment
therapy 132 139 432 439 I-treatment

Any 0 3 440 443 O
radiation 4 13 444 453 B-treatment
therapy 14 21 454 461 I-treatment
for 22 25 462 465 O
the 26 29 466 469 O
currently 30 39 470 479 O
diagnosed 40 49 480 489 O
breast 50 56 490 496 B-cancer
cancer 57 63 497 503 I-cancer
prior 64 69 504 509 B-treatment
to 70 72 510 512 I-treatment
randomization 73 86 513 526 I-treatment

At 0 2 527 529 O
the 3 6 530 533 O
time 7 11 534 538 O
of 12 14 539 541 O
definitive 15 25 542 552 B-treatment
surgery 26 33 553 560 I-treatment
, 33 34 560 561 O
all 35 38 562 565 O
removed 39 46 566 573 O
axillary 47 55 574 582 O
nodes 56 61 583 588 O
must 62 66 589 593 O
be 67 69 594 596 O
histologically 70 84 597 611 O
free 85 89 612 616 O
from 90 94 617 621 O
cancer 95 101 622 628 B-cancer

Axillary 0 8 629 637 B-treatment
node 9 13 638 642 I-treatment
dissection 14 24 643 653 I-treatment

Definitive 0 10 654 664 O
clinical 11 19 665 673 O
or 20 22 674 676 O
radiologic 23 33 677 687 O
evidence 34 42 688 696 O
of 43 45 697 699 O
metastatic 46 56 700 710 B-cancer
disease 57 64 711 718 I-cancer

Documentation 0 13 719 732 O
of 14 16 733 735 O
axillary 17 25 736 744 O
nodal 26 31 745 750 O
positivity 32 42 751 761 O
before 43 49 762 768 O
neoadjuvant 50 61 769 780 B-treatment
therapy 62 69 781 788 I-treatment
by 70 72 789 791 O
sentinel 73 81 792 800 B-treatment
node 82 86 801 805 I-treatment
biopsy 87 93 806 812 I-treatment
alone 94 99 813 818 O

For 0 3 819 822 O
patients 4 12 823 831 O
who 13 16 832 835 O
receive 17 24 836 843 O
adjuvant 25 33 844 852 B-treatment
chemotherapy 34 46 853 865 I-treatment
after 47 52 866 871 O
surgery 53 60 872 879 B-treatment
, 60 61 879 880 O
a 62 63 881 882 O
maximum 64 71 883 890 O
of 72 74 891 893 O
12 75 77 894 896 B-upper_bound
weeks 78 83 897 902 I-upper_bound
of 84 86 903 905 O
intended 87 95 906 914 O
chemotherapy 96 108 915 927 O
may 109 112 928 931 O
be 113 115 932 934 O
administered 116 128 935 947 O
but 129 132 948 951 O
must 133 137 952 956 O
be 138 140 957 959 O
completed 141 150 960 969 O
before 151 157 970 976 O
randomization 158 171 977 990 O

For 0 3 991 994 O
patients 4 12 995 1003 O
who 13 16 1004 1007 O
undergo 17 24 1008 1015 O
lumpectomy 25 35 1016 1026 B-treatment
, 35 36 1026 1027 O
the 37 40 1028 1031 O
margins 41 48 1032 1039 O
of 49 51 1040 1042 O
the 52 55 1043 1046 O
resected 56 64 1047 1055 O
specimen 65 73 1056 1064 O
or 74 76 1065 1067 O
re 77 79 1068 1070 O
- 79 80 1070 1071 O
excision 80 88 1071 1079 O
must 89 93 1080 1084 O
be 94 96 1085 1087 O
histologically 97 111 1088 1102 O
free 112 116 1103 1107 O
of 117 119 1108 1110 O
invasive 120 128 1111 1119 B-cancer
tumor 129 134 1120 1125 I-cancer
and 135 138 1126 1129 O
DCIS 139 143 1130 1134 B-cancer
as 144 146 1135 1137 O
determined 147 157 1138 1148 O
by 158 160 1149 1151 O
the 161 164 1152 1155 O
local 165 170 1156 1161 O
pathologist 171 182 1162 1173 O

For 0 3 1174 1177 O
patients 4 12 1178 1186 O
who 13 16 1187 1190 O
undergo 17 24 1191 1198 O
mastectomy 25 35 1199 1209 B-treatment
, 35 36 1209 1210 O
the 37 40 1211 1214 O
margins 41 48 1215 1222 O
must 49 53 1223 1227 O
be 54 56 1228 1230 O
histologically 57 71 1231 1245 O
free 72 76 1246 1250 O
of 77 79 1251 1253 O
residual 80 88 1254 1262 O
( 89 90 1263 1264 O
microscopic 90 101 1264 1275 O
or 102 104 1276 1278 O
gross 105 110 1279 1284 O
) 110 111 1284 1285 O
tumor 112 117 1286 1291 B-cancer

History 0 7 1292 1299 O
of 8 10 1300 1302 O
non 11 14 1303 1306 B-cancer
- 14 15 1306 1307 I-cancer
breast 15 21 1307 1313 I-cancer
malignancies 22 34 1314 1326 I-cancer
( 35 36 1327 1328 O
except 36 42 1328 1334 O
for 43 46 1335 1338 O
in 47 49 1339 1341 B-cancer
situ 50 54 1342 1346 I-cancer
cancers 55 62 1347 1354 I-cancer
treated 63 70 1355 1362 O
only 71 75 1363 1367 O
by 76 78 1368 1370 O
local 79 84 1371 1376 B-treatment
excision 85 93 1377 1385 I-treatment
and 94 97 1386 1389 O
basal 98 103 1390 1395 B-cancer
cell 104 108 1396 1400 I-cancer
and 109 112 1401 1404 O
squamous 113 121 1405 1413 B-cancer
cell 122 126 1414 1418 I-cancer
carcinomas 127 137 1419 1429 I-cancer
of 138 140 1430 1432 I-cancer
the 141 144 1433 1436 I-cancer
skin 145 149 1437 1441 I-cancer
) 149 150 1441 1442 O
within 151 157 1443 1449 O
5 158 159 1450 1451 B-upper_bound
years 160 165 1452 1457 I-upper_bound
prior 166 171 1458 1463 I-upper_bound
to 172 174 1464 1466 O
randomization 175 188 1467 1480 O

N2 0 2 1481 1483 B-cancer
or 3 5 1484 1486 O
N3 6 8 1487 1489 B-cancer
disease 9 16 1490 1497 I-cancer
detected 17 25 1498 1506 O
clinically 26 36 1507 1517 O
or 37 39 1518 1520 O
by 40 42 1521 1523 O
imaging 43 50 1524 1531 B-treatment

Other 0 5 1532 1537 O
non 6 9 1538 1541 B-cancer
- 9 10 1541 1542 I-cancer
malignant 10 19 1542 1551 I-cancer
systemic 20 28 1552 1560 I-cancer
disease 29 36 1561 1568 I-cancer
that 37 41 1569 1573 O
would 42 47 1574 1579 O
preclude 48 56 1580 1588 O
the 57 60 1589 1592 O
patient 61 68 1593 1600 O
from 69 73 1601 1605 O
receiving 74 83 1606 1615 O
study 84 89 1616 1621 B-treatment
treatment 90 99 1622 1631 I-treatment
or 100 102 1632 1634 O
would 103 108 1635 1640 O
prevent 109 116 1641 1648 O
required 117 125 1649 1657 O
follow 126 132 1658 1664 O
- 132 133 1664 1665 O
up 133 135 1665 1667 O

Patient 0 7 1668 1675 B-treatment
must 8 12 1676 1680 I-treatment
have 13 17 1681 1685 I-treatment
clinically 18 28 1686 1696 I-treatment
T1 29 31 1697 1699 I-treatment
- 31 32 1699 1700 I-treatment
3 32 33 1700 1701 I-treatment
, 33 34 1701 1702 I-treatment
N1 35 37 1703 1705 I-treatment
breast 38 44 1706 1712 I-treatment
cancer 45 51 1713 1719 I-treatment
at 52 54 1720 1722 I-treatment
the 55 58 1723 1726 I-treatment
time 59 63 1727 1731 I-treatment
of 64 66 1732 1734 I-treatment
diagnosis 67 76 1735 1744 I-treatment
( 77 78 1745 1746 I-treatment
before 78 84 1746 1752 I-treatment
neoadjuvant 85 96 1753 1764 I-treatment
therapy 97 104 1765 1772 I-treatment
) 104 105 1772 1773 I-treatment

Patient 0 7 1774 1781 O
must 8 12 1782 1786 O
have 13 17 1787 1791 O
completed 18 27 1792 1801 O
a 28 29 1802 1803 O
minimum 30 37 1804 1811 O
of 38 40 1812 1814 O
8 41 42 1815 1816 B-lower_bound
weeks 43 48 1817 1822 I-lower_bound
of 49 51 1823 1825 O
standard 52 60 1826 1834 O
neoadjuvant 61 72 1835 1846 B-treatment
chemotherapy 73 85 1847 1859 I-treatment
consisting 86 96 1860 1870 O
of 97 99 1871 1873 O
an 100 102 1874 1876 O
anthracycline 103 116 1877 1890 B-treatment
and/or 117 123 1891 1897 O
taxane 124 130 1898 1904 B-treatment
- 130 131 1904 1905 I-treatment
based 131 136 1905 1910 I-treatment
regimen 137 144 1911 1918 I-treatment

Patient 0 7 1919 1926 O
must 8 12 1927 1931 O
have 13 17 1932 1936 O
had 18 21 1937 1940 O
pathologic 22 32 1941 1951 O
confirmation 33 45 1952 1964 O
of 46 48 1965 1967 O
axillary 49 57 1968 1976 O
nodal 58 63 1977 1982 O
involvement 64 75 1983 1994 O
at 76 78 1995 1997 O
presentation 79 91 1998 2010 O
( 92 93 2011 2012 O
before 93 99 2012 2018 O
neoadjuvant 100 111 2019 2030 B-treatment
therapy 112 119 2031 2038 I-treatment
) 119 120 2038 2039 O
based 121 126 2040 2045 O
on 127 129 2046 2048 O
either 130 136 2049 2055 O
a 137 138 2056 2057 O
positive 139 147 2058 2066 O
fine 148 152 2067 2071 B-treatment
needle 153 159 2072 2078 I-treatment
aspirate 160 168 2079 2087 I-treatment
( 169 170 2088 2089 I-treatment
FNA 170 173 2089 2092 I-treatment
) 173 174 2092 2093 I-treatment
( 175 176 2094 2095 O
demonstrating 176 189 2095 2108 O
malignant 190 199 2109 2118 O
cells 200 205 2119 2124 O
) 205 206 2124 2125 O
or 207 209 2126 2128 O
positive 210 218 2129 2137 B-treatment
core 219 223 2138 2142 I-treatment
needle 224 230 2143 2149 I-treatment
biopsy 231 237 2150 2156 I-treatment
( 238 239 2157 2158 O
demonstrating 239 252 2158 2171 O
invasive 253 261 2172 2180 O
adenocarcinoma 262 276 2181 2195 B-cancer
) 276 277 2195 2196 O

Patient 0 7 2197 2204 O
who 8 11 2205 2208 O
have 12 16 2209 2213 O
undergone 17 26 2214 2223 O
either 27 33 2224 2230 O
a 34 35 2231 2232 O
total 36 41 2233 2238 O
mastectomy 42 52 2239 2249 B-treatment
or 53 55 2250 2252 O
a 56 57 2253 2254 O
lumpectomy 58 68 2255 2265 B-treatment

Patients 0 8 2266 2274 O
must 9 13 2275 2279 O
have 14 18 2280 2284 O
had 19 22 2285 2288 O
HER2 23 27 2289 2293 O
testing 28 35 2294 2301 O
performed 36 45 2302 2311 O
on 46 48 2312 2314 O
the 49 52 2315 2318 O
primary 53 60 2319 2326 B-cancer
breast 61 67 2327 2333 I-cancer
tumor 68 73 2334 2339 I-cancer
before 74 80 2340 2346 B-treatment
neoadjuvant 81 92 2347 2358 I-treatment
chemotherapy 93 105 2359 2371 I-treatment
according 106 115 2372 2381 O
to 116 118 2382 2384 O
the 119 122 2385 2388 O
current 123 130 2389 2396 O
ASCO 131 135 2397 2401 O
/ 135 136 2401 2402 O
CAP 136 139 2402 2405 O
guideline 140 149 2406 2415 O
recommendations 150 165 2416 2431 O
for 166 169 2432 2435 O
human 170 175 2436 2441 O
epidermal 176 185 2442 2451 O
growth 186 192 2452 2458 O
factor 193 199 2459 2465 O
receptor 200 208 2466 2474 O
2 209 210 2475 2476 O
testing 211 218 2477 2484 O
in 219 221 2485 2487 O
Breast 222 228 2488 2494 B-cancer
Cancer 229 235 2495 2501 I-cancer
( 236 237 2502 2503 O
http://www.asco.org 237 256 2503 2522 O
) 256 257 2522 2523 O

Patients 0 8 2524 2532 O
must 9 13 2533 2537 O
have 14 18 2538 2542 O
had 19 22 2543 2546 O
estrogen 23 31 2547 2555 O
receptor 32 40 2556 2564 O
( 41 42 2565 2566 O
ER 42 44 2566 2568 O
) 44 45 2568 2569 O
analysis 46 54 2570 2578 O
performed 55 64 2579 2588 O
on 65 67 2589 2591 O
the 68 71 2592 2595 O
primary 72 79 2596 2603 O
breast 80 86 2604 2610 B-cancer
tumor 87 92 2611 2616 I-cancer
before 93 99 2617 2623 O
neoadjuvant 100 111 2624 2635 B-treatment
therapy 112 119 2636 2643 I-treatment
according 120 129 2644 2653 O
to 130 132 2654 2656 O
current 133 140 2657 2664 O
American 141 149 2665 2673 O
Society 150 157 2674 2681 O
of 158 160 2682 2684 O
Clinical 161 169 2685 2693 O
Oncology 170 178 2694 2702 O
( 179 180 2703 2704 O
ASCO)/College 180 193 2704 2717 O
of 194 196 2718 2720 O
American 197 205 2721 2729 O
Pathologists 206 218 2730 2742 O
( 219 220 2743 2744 O
CAP 220 223 2744 2747 O
) 223 224 2747 2748 O
guideline 225 234 2749 2758 O
recommendations 235 250 2759 2774 O
for 251 254 2775 2778 O
hormone 255 262 2779 2786 O
receptor 263 271 2787 2795 O
testing 272 279 2796 2803 O

Patients 0 8 2804 2812 O
with 9 13 2813 2817 O
histologically 14 28 2818 2832 O
positive 29 37 2833 2841 B-cancer
axillary 38 46 2842 2850 I-cancer
nodes 47 52 2851 2856 I-cancer
post 53 57 2857 2861 B-treatment
neoadjuvant 58 69 2862 2873 I-treatment
therapy 70 77 2874 2881 I-treatment

Patients 0 8 2882 2890 O
with 9 13 2891 2895 O
microscopic 14 25 2896 2907 B-cancer
positive 26 34 2908 2916 I-cancer
margins 35 42 2917 2924 I-cancer
after 43 48 2925 2930 O
definitive 49 59 2931 2941 O
surgery 60 67 2942 2949 B-treatment

Patients 0 8 2950 2958 O
with 9 13 2959 2963 O
pathologic 14 24 2964 2974 B-treatment
staging 25 32 2975 2982 I-treatment
of 33 35 2983 2985 O
ypN0(i+ 36 43 2986 2993 B-clinical_variable
) 43 44 2993 2994 I-clinical_variable
or 45 47 2995 2997 O
ypN0(mol+ 48 57 2998 3007 B-clinical_variable
) 57 58 3007 3008 I-clinical_variable

Pregnancy 0 9 3009 3018 B-pregnancy
or 10 12 3019 3021 O
lactation 13 22 3022 3031 O
at 23 25 3032 3034 O
the 26 29 3035 3038 O
time 30 34 3039 3043 O
of 35 37 3044 3046 O
study 38 43 3047 3052 O
entry 44 49 3053 3058 O

Pregnancy 0 9 3059 3068 B-pregnancy
testing 10 17 3069 3076 O
must 18 22 3077 3081 O
be 23 25 3082 3084 O
performed 26 35 3085 3094 O
within 36 42 3095 3101 O
2 43 44 3102 3103 B-upper_bound
weeks 45 50 3104 3109 I-upper_bound
prior 51 56 3110 3115 I-upper_bound
to 57 59 3116 3118 O
randomization 60 73 3119 3132 B-treatment
according 74 83 3133 3142 O
to 84 86 3143 3145 O
institutional 87 100 3146 3159 O
standards 101 110 3160 3169 O
for 111 114 3170 3173 O
women 115 120 3174 3179 B-gender
of 121 123 3180 3182 O
childbearing 124 136 3183 3195 O
potential 137 146 3196 3205 O

Prior 0 5 3206 3211 B-treatment
breast 6 12 3212 3218 I-treatment
or 13 15 3219 3221 O
thoracic 16 24 3222 3230 B-treatment
radiation 25 34 3231 3240 I-treatment
therapy 35 42 3241 3248 I-treatment
( 43 44 3249 3250 I-treatment
RT 44 46 3250 3252 I-treatment
) 46 47 3252 3253 I-treatment
for 48 51 3254 3257 O
any 52 55 3258 3261 O
condition 56 65 3262 3271 O

Psychiatric 0 11 3272 3283 B-chronic_disease
or 12 14 3284 3286 O
addictive 15 24 3287 3296 B-chronic_disease
disorders 25 34 3297 3306 I-chronic_disease
or 35 37 3307 3309 O
other 38 43 3310 3315 O
conditions 44 54 3316 3326 O
that 55 59 3327 3331 O
, 59 60 3331 3332 O
in 61 63 3333 3335 O
the 64 67 3336 3339 O
opinion 68 75 3340 3347 O
of 76 78 3348 3350 O
the 79 82 3351 3354 O
investigator 83 95 3355 3367 O
, 95 96 3367 3368 O
would 97 102 3369 3374 O
preclude 103 111 3375 3383 O
the 112 115 3384 3387 O
patient 116 123 3388 3395 O
from 124 128 3396 3400 O
meeting 129 136 3401 3408 O
the 137 140 3409 3412 O
study 141 146 3413 3418 O
requirements 147 159 3419 3431 O

Sentinel 0 8 3432 3440 B-treatment
node 9 13 3441 3445 I-treatment
biopsy 14 20 3446 3452 I-treatment
alone 21 26 3453 3458 O

Sentinel 0 8 3459 3467 B-treatment
node 9 13 3468 3472 I-treatment
biopsy 14 20 3473 3479 I-treatment
followed 21 29 3480 3488 O
by 30 32 3489 3491 O
axillary 33 41 3492 3500 B-treatment
node 42 46 3501 3505 I-treatment
dissection 47 57 3506 3516 I-treatment

Synchronous 0 11 3517 3528 O
or 12 14 3529 3531 O
previous 15 23 3532 3540 O
contralateral 24 37 3541 3554 B-cancer
invasive 38 46 3555 3563 I-cancer
breast 47 53 3564 3570 I-cancer
cancer 54 60 3571 3577 I-cancer
or 61 63 3578 3580 O
DCIS 64 68 3581 3585 B-cancer

T4 0 2 3586 3588 B-cancer
tumors 3 9 3589 3595 I-cancer
including 10 19 3596 3605 O
inflammatory 20 32 3606 3618 B-cancer
breast 33 39 3619 3625 I-cancer
cancer 40 46 3626 3632 I-cancer

The 0 3 3633 3636 O
interval 4 12 3637 3645 O
between 13 20 3646 3653 O
the 21 24 3654 3657 O
last 25 29 3658 3662 O
surgery 30 37 3663 3670 B-treatment
for 38 41 3671 3674 O
breast 42 48 3675 3681 B-cancer
cancer 49 55 3682 3688 I-cancer
( 56 57 3689 3690 O
including 57 66 3690 3699 O
re 67 69 3700 3702 B-treatment
- 69 70 3702 3703 I-treatment
excision 70 78 3703 3711 I-treatment
of 79 81 3712 3714 I-treatment
margins 82 89 3715 3722 I-treatment
) 89 90 3722 3723 O
and 91 94 3724 3727 O
randomization 95 108 3728 3741 B-treatment
must 109 113 3742 3746 O
be 114 116 3747 3749 O
no 117 119 3750 3752 O
more 120 124 3753 3757 O
than 125 129 3758 3762 O
70 130 132 3763 3765 B-lower_bound
days 133 137 3766 3770 I-lower_bound

The 0 3 3771 3774 O
patient 4 11 3775 3782 O
must 12 16 3783 3787 O
have 17 21 3788 3792 O
an 22 24 3793 3795 O
Eastern 25 32 3796 3803 B-clinical_variable
Cooperative 33 44 3804 3815 I-clinical_variable
Oncology 45 53 3816 3824 I-clinical_variable
Group 54 59 3825 3830 I-clinical_variable
( 60 61 3831 3832 I-clinical_variable
ECOG 61 65 3832 3836 I-clinical_variable
) 65 66 3836 3837 I-clinical_variable
performance 67 78 3838 3849 I-clinical_variable
status 79 85 3850 3856 I-clinical_variable
of 86 88 3857 3859 O
0 89 90 3860 3861 B-lower_bound
or 91 93 3862 3864 O
1 94 95 3865 3866 B-upper_bound

The 0 3 3867 3870 O
patient 4 11 3871 3878 O
must 12 16 3879 3883 O
have 17 21 3884 3888 O
recovered 22 31 3889 3898 O
from 32 36 3899 3903 O
surgery 37 44 3904 3911 B-treatment
with 45 49 3912 3916 O
the 50 53 3917 3920 O
incision 54 62 3921 3929 O
completely 63 73 3930 3940 O
healed 74 80 3941 3947 O
and 81 84 3948 3951 O
no 85 87 3952 3954 O
signs 88 93 3955 3960 O
of 94 96 3961 3963 O
infection 97 106 3964 3973 B-chronic_disease

clinical 0 8 3974 3982 O
axillary 9 17 3983 3991 O
nodal 18 23 3992 3997 B-cancer
involvement 24 35 3998 4009 I-cancer
can 36 39 4010 4013 O
be 40 42 4014 4016 O
assessed 43 51 4017 4025 O
by 52 54 4026 4028 O
palpation 55 64 4029 4038 B-treatment
, 64 65 4038 4039 O
ultrasound 66 76 4040 4050 B-treatment
, 76 77 4050 4051 O
CT 78 80 4052 4054 B-treatment
scan 81 85 4055 4059 I-treatment
, 85 86 4059 4060 O
magnetic 87 95 4061 4069 B-treatment
resonance 96 105 4070 4079 I-treatment
imaging 106 113 4080 4087 I-treatment
( 114 115 4088 4089 I-treatment
MRI 115 118 4089 4092 I-treatment
) 118 119 4092 4093 I-treatment
, 119 120 4093 4094 O
positron 121 129 4095 4103 B-treatment
emission 130 138 4104 4112 I-treatment
tomography 139 149 4113 4123 I-treatment
( 150 151 4124 4125 I-treatment
PET 151 154 4125 4128 I-treatment
) 154 155 4128 4129 I-treatment
scan 156 160 4130 4134 I-treatment
, 160 161 4134 4135 O
or 162 164 4136 4138 O
PET 165 168 4139 4142 B-treatment
/ 168 169 4142 4143 I-treatment
CT 169 171 4143 4145 I-treatment
scan 172 176 4146 4150 I-treatment

documentation 0 13 4151 4164 O
of 14 16 4165 4167 O
axillary 17 25 4168 4176 O
nodal 26 31 4177 4182 O
positivity 32 42 4183 4193 O
by 43 45 4194 4196 O
sentinel 46 54 4197 4205 B-treatment
node 55 59 4206 4210 I-treatment
biopsy 60 66 4211 4217 I-treatment
( 67 68 4218 4219 O
before 68 74 4219 4225 O
neoadjuvant 75 86 4226 4237 B-treatment
therapy 87 94 4238 4245 I-treatment
) 94 95 4245 4246 O

patients 0 8 4247 4255 O
who 9 12 4256 4259 O
are 13 16 4260 4263 O
found 17 22 4264 4269 O
to 23 25 4270 4272 O
be 26 28 4273 4275 O
pathologically 29 43 4276 4290 O
node 44 48 4291 4295 O
- 48 49 4295 4296 O
positive 49 57 4296 4304 O
at 58 60 4305 4307 O
the 61 64 4308 4311 O
time 65 69 4312 4316 O
of 70 72 4317 4319 O
surgery 73 80 4320 4327 B-treatment
, 80 81 4327 4328 O
based 82 87 4329 4334 O
on 88 90 4335 4337 O
sentinel 91 99 4338 4346 B-treatment
node 100 104 4347 4351 I-treatment
biopsy 105 111 4352 4358 I-treatment
alone 112 117 4359 4364 O
, 117 118 4364 4365 O
are 119 122 4366 4369 O
candidates 123 133 4370 4380 O
for 134 137 4381 4384 O
A011202 138 145 4385 4392 O
, 145 146 4392 4393 O
a 147 148 4394 4395 O
study 149 154 4396 4401 O
developed 155 164 4402 4411 O
by 165 167 4412 4414 O
the 168 171 4415 4418 O
Alliance 172 180 4419 4427 O
in 181 183 4428 4430 O
Oncology 184 192 4431 4439 O
, 192 193 4439 4440 O
an 194 196 4441 4443 O
NCI 197 200 4444 4447 O
Cooperative 201 212 4448 4459 O
Group 213 218 4460 4465 O

patients 0 8 4466 4474 O
who 9 12 4475 4478 O
have 13 17 4479 4483 O
a 18 19 4484 4485 O
primary 20 27 4486 4493 B-cancer
tumor 28 33 4494 4499 I-cancer
that 34 38 4500 4504 O
is 39 41 4505 4507 O
either 42 48 4508 4514 O
HER2 49 53 4515 4519 B-cancer
- 53 54 4519 4520 I-cancer
positive 54 62 4520 4528 I-cancer
or 63 65 4529 4531 O
HER2 66 70 4532 4536 B-cancer
- 70 71 4536 4537 I-cancer
negative 71 79 4537 4545 I-cancer

patients 0 8 4546 4554 O
with 9 13 4555 4559 O
margins 14 21 4560 4567 O
positive 22 30 4568 4576 O
for 31 34 4577 4580 O
lobular 35 42 4581 4588 B-cancer
carcinoma 43 52 4589 4598 I-cancer
in 53 55 4599 4601 I-cancer
situ 56 60 4602 4606 I-cancer
[ 61 62 4607 4608 I-cancer
LCIS 62 66 4608 4612 I-cancer
] 66 67 4612 4613 I-cancer
are 68 71 4614 4617 O
eligible 72 80 4618 4626 O
without 81 88 4627 4634 O
additional 89 99 4635 4645 O
resection 100 109 4646 4655 O

patients 0 8 4656 4664 O
with 9 13 4665 4669 O
synchronous 14 25 4670 4681 B-cancer
and/or 26 32 4682 4688 I-cancer
previous 33 41 4689 4697 I-cancer
contralateral 42 55 4698 4711 I-cancer
LCIS 56 60 4712 4716 I-cancer

patients 0 8 4717 4725 O
with 9 13 4726 4730 O
synchronous 14 25 4731 4742 O
or 26 28 4743 4745 O
previous 29 37 4746 4754 O
ipsilateral 38 49 4755 4766 B-cancer
LCIS 50 54 4767 4771 I-cancer

there 0 5 4772 4777 O
is 6 8 4778 4780 O
residual 9 17 4781 4789 O
invasive 18 26 4790 4798 B-cancer
carcinoma 27 36 4799 4808 I-cancer
in 37 39 4809 4811 O
the 40 43 4812 4815 O
surgical 44 52 4816 4824 B-treatment
breast 53 59 4825 4831 I-treatment
specimen 60 68 4832 4840 O
or 69 71 4841 4843 O
whether 72 79 4844 4851 O
there 80 85 4852 4857 O
is 86 88 4858 4860 O
evidence 89 97 4861 4869 O
of 98 100 4870 4872 O
pathologic 101 111 4873 4883 O
complete 112 120 4884 4892 O
response 121 129 4893 4901 O

